Urethral stent and preparation method and application thereof
A urethral and joint technology, applied in the field of urethral stent and its preparation, can solve the problems of repairing or treating damage, increasing economic burden, urethral stricture, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0077] This embodiment provides a urethral stent, comprising a stent matrix and a drug film arranged on the outer surface of the stent matrix, wherein the thickness of the drug film is 0.05mm; the stent matrix is a stent matrix with a balloon of 8F polyurethane material (such as figure 1 shown), the sectional view of the stent matrix along A-A is as figure 2 shown.
[0078] This embodiment provides a method for preparing a urethral stent, comprising the following steps:
[0079] (1) Preparation of drug film solution: 78 parts by weight of one-component HTV silicone rubber, 20 parts by weight of dexamethasone (particle size is 1000 mesh), 1 part by weight of hydrogen-containing silicone oil and 1 part by weight of platinum catalyst are dissolved in 200 parts by weight Parts of n-hexane, mixed and stirred evenly to obtain the film liquid;
[0080] (2) Preparation of urethral stent: Take the stent matrix with a balloon of 8F polyurethane material, apply a 100 mm length of dr...
Embodiment 2
[0095] This embodiment provides a urethral stent, comprising a stent base and a drug film arranged on the outer surface of the stent base, wherein the thickness of the drug film is 0.5mm; the stent base is a single-lumen urinary catheter (model 8F) made of silicone rubber .
[0096] This embodiment provides a method for preparing a urethral stent, comprising the following steps:
[0097] (1) Preparation of drug film solution: Mix 60 parts by weight of single-component HTV liquid silicone rubber, 20 parts by weight of mometasone furoate (particle size is 3000 mesh), 0.2 parts by weight of hydrogen-containing silicone oil and 0.2 parts by weight of platinum catalyst, Obtain the drug film liquid;
[0098] (2) Preparation of the urethral stent: take the stent matrix of 8F silicone rubber material, put the drug film liquid and the stent matrix in the mold, and cure the drug film on the stent matrix by heating and vulcanizing, and obtain the urethral stent after demolding .
[00...
Embodiment 3
[0103] This embodiment provides a urethral stent, comprising a stent base and a drug film disposed on the outer surface of the stent base, wherein the thickness of the drug film is 1mm; the stent base is a braided stent made of metal (type 8F).
[0104] This embodiment provides a method for preparing a urethral stent, comprising the following steps:
[0105] (1) Preparation of drug film solution: Mix 30 parts by weight of two-component room temperature vulcanizing liquid silicone rubber A, 10 parts by weight of mometasone furoate (with a particle size of 3000 mesh), and 0.1 part by weight of platinum catalyst to obtain drug film solution A; Mix 30 parts by weight of two-component room temperature vulcanizing liquid silicone rubber B, 10 parts by weight of mometasone furoate (with a particle size of 3000 mesh), and 0.1 part by weight of hydrogen-containing silicone oil to obtain the drug film solution B;
[0106] (2) Preparation of urethral stent: Take the stent matrix woven an...
PUM
Property | Measurement | Unit |
---|---|---|
Crosslink density | aaaaa | aaaaa |
Thickness | aaaaa | aaaaa |
Thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com